Philip Gao

704 total citations
16 papers, 435 citations indexed

About

Philip Gao is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Philip Gao has authored 16 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Philip Gao's work include RNA Research and Splicing (7 papers), RNA modifications and cancer (6 papers) and RNA and protein synthesis mechanisms (4 papers). Philip Gao is often cited by papers focused on RNA Research and Splicing (7 papers), RNA modifications and cancer (6 papers) and RNA and protein synthesis mechanisms (4 papers). Philip Gao collaborates with scholars based in United States, China and Canada. Philip Gao's co-authors include Anuradha Roy, Lan Lan, Liang Xu, Xiaoqing Wu, Jeffrey Aubé, Rebecca T. Marquez, Steven A. Rogers, Dan A. Dixon, Benjamin A. Turner and Scott Lovell and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Cancer Research.

In The Last Decade

Philip Gao

13 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Gao United States 9 311 61 60 53 37 16 435
Mario Hlevnjak Germany 13 201 0.6× 54 0.9× 38 0.6× 31 0.6× 29 0.8× 19 367
Frédéric Villard Switzerland 10 269 0.9× 59 1.0× 83 1.4× 43 0.8× 88 2.4× 14 504
Amit Ketkar United States 17 432 1.4× 60 1.0× 77 1.3× 29 0.5× 12 0.3× 30 603
Levon Halabelian Canada 15 438 1.4× 102 1.7× 45 0.8× 100 1.9× 56 1.5× 28 626
Andreas Naschberger Austria 11 320 1.0× 19 0.3× 75 1.3× 15 0.3× 25 0.7× 22 449
Thea van den Bosch Netherlands 8 301 1.0× 73 1.2× 30 0.5× 17 0.3× 75 2.0× 11 404
Yvette Newbatt United Kingdom 12 451 1.5× 54 0.9× 22 0.4× 20 0.4× 36 1.0× 13 583
Qijia Yu China 7 242 0.8× 96 1.6× 90 1.5× 26 0.5× 61 1.6× 9 394
Jihui Du China 9 180 0.6× 40 0.7× 64 1.1× 12 0.2× 24 0.6× 17 311
Rena McKinnon United States 8 173 0.6× 32 0.5× 13 0.2× 32 0.6× 37 1.0× 9 316

Countries citing papers authored by Philip Gao

Since Specialization
Citations

This map shows the geographic impact of Philip Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Gao more than expected).

Fields of papers citing papers by Philip Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Gao. The network helps show where Philip Gao may publish in the future.

Co-authorship network of co-authors of Philip Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Gao. A scholar is included among the top collaborators of Philip Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Gao. Philip Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Kashipathy, M.M., Philip Gao, David K. Johnson, et al.. (2024). HSV ‐1 ICP0 dimer domain adopts a novel β‐barrel fold. Proteins Structure Function and Bioinformatics. 92(7). 830–841.
3.
Sharma, Horrick, Pragya Sharma, Philip Gao, et al.. (2024). Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer. European Journal of Medicinal Chemistry. 275. 116598–116598. 6 indexed citations
4.
Kerr, Catherine M., Yousef M. Alhammad, Peter R. McDonald, et al.. (2024). Mutation of a highly conserved isoleucine residue in loop 2 of several β-coronavirus macrodomains indicates that enhanced ADP-ribose binding is detrimental for replication. Journal of Virology. 98(11). e0131324–e0131324. 4 indexed citations
5.
Benson, David R., Bin Deng, M.M. Kashipathy, et al.. (2023). The N‐terminal intrinsically disordered region of Ncb5or docks with the cytochrome b 5 core to form a helical motif that is of ancient origin. Proteins Structure Function and Bioinformatics. 92(4). 554–566. 1 indexed citations
6.
Tang, Zhichao, Xiao Wang, Mikhail Reibarkh, et al.. (2021). Recognition of single-stranded nucleic acids by small-molecule splicing modulators. Nucleic Acids Research. 49(14). 7870–7883. 19 indexed citations
7.
Alhammad, Yousef M., M.M. Kashipathy, Anuradha Roy, et al.. (2020). The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase. Journal of Virology. 95(3). 86 indexed citations
8.
Benson, David R., Scott Lovell, N. Mehzabeen, et al.. (2019). Crystal structures of the naturally fused CS and cytochrome b 5 reductase (b 5R) domains of Ncb5or reveal an expanded CS fold, extensive CS–b 5R interactions and productive binding of the NAD(P)+ nicotinamide ring. Acta Crystallographica Section D Structural Biology. 75(7). 628–638. 5 indexed citations
9.
Lan, Lan, M.M. Kashipathy, Justin T. Douglas, et al.. (2019). Crystal and solution structures of human oncoprotein Musashi‐2 N‐terminal RNA recognition motif 1. Proteins Structure Function and Bioinformatics. 88(4). 573–583. 9 indexed citations
10.
Lan, Lan, Hao Liu, Amber R. Smith, et al.. (2018). Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins. BMC Cancer. 18(1). 809–809. 28 indexed citations
11.
Yu, Jia, Lan Lan, Steven A. Rogers, et al.. (2017). Identification of novel small molecule Beclin 1 mimetics activating autophagy. Oncotarget. 8(31). 51355–51369. 13 indexed citations
12.
Lan, Lan, et al.. (2017). Human oncoprotein Musashi-2 N-terminal RNA recognition motif backbone assignment and identification of RNA-binding pocket. Oncotarget. 8(63). 106587–106597. 11 indexed citations
13.
Lan, Lan, Amber R. Smith, Jia Yu, et al.. (2015). Natural product (−)‐gossypol inhibits colon cancer cell growth by targeting RNA‐binding protein Musashi‐1. Molecular Oncology. 9(7). 1406–1420. 98 indexed citations
14.
Wu, Xiaoqing, Lan Lan, Rebecca T. Marquez, et al.. (2015). Identification and Validation of Novel Small Molecule Disruptors of HuR-mRNA Interaction. ACS Chemical Biology. 10(6). 1476–1484. 125 indexed citations
15.
Wu, Xiaoqing, Lan Lan, Amber R. Smith, et al.. (2015). Abstract 2449: Targeting an “undruggable” RNA-binding protein: Discovery of small molecule inhibitors of HuR for novel breast cancer therapy. Cancer Research. 75(15_Supplement). 2449–2449.
16.
Li, Conggang, Philip Gao, Huajun Qin, et al.. (2007). Uniformly Aligned Full-Length Membrane Proteins in Liquid Crystalline Bilayers for Structural Characterization. Journal of the American Chemical Society. 129(17). 5304–5305. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026